<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age>30</patient-age><report-id>US-PFIZER INC-2013032358</report-id><gender>male</gender><reactions><reaction>seizures again</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>Dilantin</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Seizures</indication></indications><patient-age>30</patient-age><outcomes/><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>psur</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4254120_P31</messagenumb>
		<messagesenderidentifier>PFIZERINC</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151550</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>1</safetyreportversion>
		<safetyreportid>US-PFIZER INC-2013032358</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2013-01-23</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-23</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>2</fulfillexpeditecriteria>
		<companynumb>US-PFIZER INC-2013032358</companynumb>
		<medicallyconfirm>2</medicallyconfirm>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>US</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>PFIZERINC</senderorganization>
			<senderfamilyname>Head Drug Safety Surveillance</senderfamilyname>
			<senderstreetaddress>150 East 42nd Street</senderstreetaddress>
			<sendercity>New York</sendercity>
			<senderstate>New York</senderstate>
			<senderpostcode>10017</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>2127335544</sendertel>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receivertitle>Mr</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20785</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receivertelcountrycode>001</receivertelcountrycode>
			<receiverfax>3019183134</receiverfax>
			<receiverfaxcountrycode>001</receiverfaxcountrycode>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientonsetage>30</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientweight>102</patientweight>
			<patientheight>175</patientheight>
			<patientsex code="1">Male</patientsex>
			<resultstestsprocedures>Blood work (12Jan2013): results were unknown.</resultstestsprocedures>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Bronchitis</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>seizures again</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Drug ineffective</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Drug ineffective</reactionmeddrapt>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20130112</reactionstartdate>
				<reactionfirsttime>30</reactionfirsttime>
				<reactionfirsttimeunit>806</reactionfirsttimeunit>
				<reactionlasttime>1</reactionlasttime>
				<reactionlasttimeunit>804</reactionlasttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Dilantin</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>8-762</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Pfizer, Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>100</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugintervaldosagedefinition code="813">Total</drugintervaldosagedefinition>
				<drugdosagetext>100 mg, single</drugdosagetext>
				<drugdosageform normalized="capsule, hard">Capsule, hard</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Seizures</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2013-01-12</drugstartdate>
				<drugstartperiod>1</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<activesubstance>
					<activesubstancename>PHENYTOIN SODIUM</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>This is a spontaneous report from a non clinical study program Pfizer Helpful Answers for a contactable consumer. This 30-year old <Semaphore x="2699001" class="Race" value="White" score="1.00" ID="C41261">White and Hispanic male </Semaphore>consumer started receiving <Semaphore x="1026438" class="Medicine" value="Phenytoin sodium" score="0.87" ID="281195">phenytoin <Semaphore x="2536895" class="Procedure" value="Sodium Measurement" score="1.00" ID="C64809">sodium </Semaphore></Semaphore>(<Semaphore x="474565" class="Medicine" value="Dilantin" score="0.49" ID="241332">DILANTIN</Semaphore>) capsules on 12Jan2013 at 100 mg at an unknown frequency once <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">orally </Semaphore>for recurrent <Semaphore x="2503954" class="Procedure" value="Seizure at its Worst" score="1.00" ID="C113093">seizures</Semaphore>. The relevant medical history included <Semaphore x="1650011" class="Disease or Finding" value="Bronchitis" score="1.00" ID="C2911">bronchitis </Semaphore>since an unknown date. No relevant concomitant medications were reported. The consumer reported that on 12Jan2013 while being on <Semaphore x="1026409" class="Medicine - Phenytoin sodium - Dose" value="100 mg" score="0.49" ID=""><Semaphore x="1026438" class="Medicine" value="Phenytoin sodium" score="0.87" ID="281195">phenytoin <Semaphore x="2536895" class="Procedure" value="Sodium Measurement" score="1.00" ID="C64809">sodium </Semaphore></Semaphore>at <Semaphore x="4408393087320065" class="Medicine - Phenytoin sodium - Dose" value="100 mg" score="0.49" ID="">100 mg </Semaphore></Semaphore><Semaphore x="4408457511829505" class="Medicine - Phenytoin sodium - Frequency" value="at" score="0.49" ID="">at </Semaphore>an unknown frequency <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">orally </Semaphore>the <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore>did not work that was elaborated as the consumer experienced <Semaphore x="2503954" class="Procedure" value="Seizure at its Worst" score="1.00" ID="C113093">seizures </Semaphore>again, after 30 minutes of taking <Semaphore x="1026438" class="Medicine" value="Phenytoin sodium" score="0.87" ID="281195">phenytoin <Semaphore x="2536895" class="Procedure" value="Sodium Measurement" score="1.00" ID="C64809">sodium</Semaphore></Semaphore>. The relevant laboratory data included <Semaphore x="1608509" class="AnatomicStructure" value="Blood" score="1.00" ID="C12434">blood </Semaphore>work on 12Jan2013 but the <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">results </Semaphore>were unknown. The consumer was not taking <Semaphore x="1026494" class="Medicine" value="Phenytoin" score="0.74" ID="285426">phenytoin </Semaphore>at the time of the report (23Jan2013) as he mentioned that he had taken the <Semaphore x="1026494" class="Medicine" value="Phenytoin" score="0.74" ID="285426">phenytoin </Semaphore>only once on 12Jan2013 and had not taken it since then because he could not afford that. No therapeutic measures were taken for the reported event. Clinical <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the reported event was unknown at the time of the report (23Jan2013).</narrativeincludeclinical>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>